SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
February 01, 2024 09:00 ET
|
SPR Therapeutics, Inc.
SPR Therapeutics Announces $85 Million in Additional Funding to Advance Commercial Expansion of SPRINT PNS System.
SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024
January 16, 2024 09:00 ET
|
SPR Therapeutics, Inc.
SPR Therapeutics and the SPRINT PNS System will be featured prominently at the North American Neuromodulation Society Annual Meeting with 11 abstracts.
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
November 13, 2023 09:05 ET
|
SPR Therapeutics, Inc.
Three SPR Posters Accepted Including a President’s Choice Award for New Data from Randomized Controlled Trial on Total Knee Replacement Postoperative Pain
Aptean stärkt sein strategisches Netzwerk in der DACH-Region
July 18, 2022 09:30 ET
|
Aptean Inc.
ALPHARETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- Aptean, ein globaler Anbieter von Softwarelösungen für geschäftskritische Prozesse, gab heute die Erweiterung seines Partnernetzwerks auf dem...
Aptean Strengthens Its Strategic Network in the DACH Region
July 18, 2022 09:30 ET
|
Aptean Inc.
ALPHARETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- Today, Aptean, a global provider of mission-critical enterprise software solutions, announced the expansion of its partner network in the Swiss...
Ondine Receives Innovation Award of Excellence at World-leading Infection Conference, ICPIC 2021 for Photodisinfection Efficacy Results against COVID-19 Virus Variants including Delta
September 22, 2021 05:00 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Ondine’s nasal photodisinfection technology has been shown to eliminate the RNA signature of SARS-CoV-2, including the dominant Delta variant,...
Preventing COVID-19 with Photodisinfection – New Results Presented at European Society of Photobiology
September 18, 2021 01:27 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, Sept. 18, 2021 (GLOBE NEWSWIRE) -- Nasal decolonization is recommended by the WHO and CDC to reduce hospital acquired infections (HAIs), [1] which have been exacerbated by COVID....
Ondine Biomedical to present SARS-CoV-2 results at the 19th Congress of the European Society of Photobiology
August 03, 2021 06:00 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Ondine's technology platform is capable of painlessly and rapidly destroying a broad spectrum of bacteria, fungi, and viruses — including...
IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA
February 22, 2021 11:04 ET
|
Impulse Dynamics
MARLTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF), today announced that the National Medical Products...
GLOBAL REGULATORY ORGANIZATION CERTIFIES OPTIMIZER SMART DEVICE AS COMPLIANT FOR WHOLE-BODY MRI SCANS IN THE EU
February 16, 2021 10:45 ET
|
Impulse Dynamics
MARLTON, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, an international medical device company dedicated to improving the lives of people with heart failure (HF), today announced that...